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Abstract—The reaction of 6-hydrazino uracils 1 with isocyanates 2 gave access to an efficient one-pot synthesis of pyrazolo[3,4-
d ]pyrimidines 3 in excellent yields. © 2002 Elsevier Science Ltd. All rights reserved.
The importance of uracil and its annelated derivatives
is well recognised by synthetic1 as well as biological2
chemists. Pyrazolo[3,4-d ]pyrimidines are a class of nat-
urally occurring fused uracils that possess a wide range
of biological activity.3 Allopurinol (6-dehydroxy-pyra-
zolo[3,4-d ]pyrimidine), an effective xanthine oxidase
inhibitor,4 is in clinical use for controlling gout and
related metabolic disorders.5 Furthermore, the allopuri-
nol 1-ribo-nucleotide-like 6-azauridine-5-phosphate is a
potential antiviral and antitumor agent.6 Several
reports are available which suggest that 4-aminopyra-
zolo[3,4-d ]pyrimidine nucleosides and related com-
pounds may function as substrates for anabolic and
catabolic enzymes.7 The discovery of strong antipara-
sitic properties shown by allopurinol, its 1--D-ribose
derivative and related compounds has resulted in exten-
sive work in this area, which has been reviewed.8 How-
ever, a literature survey revealed only a few reports on
the synthesis of the parent pyrazolo[3,4-d ]pyrimidine
moiety, which usually requires drastic conditions, long
reaction times and complex synthetic pathways.
Synthetic exploitation of the nucleophilic double bond
of uracils is an important field in view of a great
variety9 of potential products. Recently, we reported10 a
novel method for the synthesis of pyrimido[4,5-
c ]pyridazines from the reaction of 6-hydrazino uracils
and acetylene dicarboxylates at room temperature. In
the present communication we describe the results of
our study of the reaction of 6-hydrazino uracils and
isocyanates, which gives access to an efficient one-pot
synthesis of pyrazolo[3,4-d ]pyrimidines and thus a
novel class of 3-amino-pyrazolo[3,4-d ]pyrimidines in
excellent yields.
A previous synthesis of pyrazolo[3,4-d ]pyrimidine
reported by Yoneda et al.11a,b involved the cycloaddi-
tion of the azahexatriene obtained from the reaction of
an arylaldehyde and a 6-uracil hydrazone. One disad-
vantage of this approach is the concomitant arylation
of the pyrazolo moiety. Earlier this class of compounds
was synthesised by fusion of 6-uracil hydrazones at
300°C.11c Another synthesis reported by Maki et al.12
required the cycloaddition of an arylhydrazone with
6-chloro-5-nitro uracil, which involved several steps.
Further, Kanazawa et al.13 synthesised pyrazolo[3,4-
d ]pyrimidines by the reaction of 6-aryledinehydrazinou-
racils with NBS (N-bromosuccinimide) in acetic acid
under refluxing conditions, which yielded triazino and
pyridazinouracils in addition to the pyrazolo[3,4-
d ]pyrimidines (Scheme 1).
Our synthetic strategy utilising 6-hydrazinouracils 1
and isocyanates 2 affords an unprecedented one-pot
Scheme 1.
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Scheme 2.
synthesis of pyrazolo[3,4-d ]pyrimidines 3 in excellent
yields.
In a very simple experimental procedure an equimolar
amount of 1,3-dimethyl-6-hydrazino uracil14 1a (0.170
g, 1 mmol) was added quickly to phenyl isocyanate 2a
(0.119 g, 1 mmol) at room temperature. An exothermic
reaction occurred. After 10 min the reaction mixture
was refluxed in ethanol (10 ml) for 20 min. On cooling
the thick precipitate of the product, which appeared in
the reaction mixture was filtered, washed with a small
amount of ethanol and dried. A 95% yield (0.257 g) of
the compound was obtained and confirmed as 3a from
spectroscopic data and elemental analysis, mp 246°C.
1H NMR 90 MHz (CDCl3+TFA)  2.95 (s, 3H), 3.30
(s, 3H), 6.75–7.20 (m, 5H). 13C NMR 75 MHz (CDCl3+
TFA)  28.0 (N3-CH3); 28.5 (N1-CH3); 107.0 (4a);
(112.2, 114.2, 120.0, 123.7 aromatic); 129.6 (C-5); 158.0
(C-7a); 158.4 (C-2); 160.0 (C-4). IR 3220, 3202, 1700
cm−1. MS 271 M+. CHN analyses (calcd %) C, 57.56;
H, 4.80; N, 25.83; (found %) C, 57.52; H, 4.75; N,
25.85. The IR spectrum showed the involvement of the
hydrazine group and the absence of the C-5 proton of
the uracil moiety in the 1H NMR spectrum evidenced in
the cyclisation process in the reaction. Similarly, com-
pounds 3b–d were prepared and the structures confi-
rmed by spectroscopic data and elemental analyses. 3b:
mp 242°C. 1H NMR 90 MHz (CDCl3+TFA)  2.95 (s,
3H), 6.80–7.25 (m, 5H). 13C NMR 75 MHz (CDCl3+
TFA)  28.8 (N3-CH3); 107.2 (4a); (111.7, 115.5, 120.2,
124.6 aromatic); 128.9 (C-5); 158.0 (C-7a); 158.5 (C-2);
160.0 (C-4). IR 3250, 3205, 3125, 1700 cm−1. MS 257
M+. CHN analysis (calcd %) C, 56.03; H, 4.28; N,
27.24; (found %) C, 56.10; H, 4.29; N, 27.20. 3c: mp
253°C. 1H NMR 90 MHz (CDCl3+TFA)  3.00 (s, 3H),
3.25 (s, 3H), 4.20 (s, 2H), 6.75–7.20 (m, 5H). 13C NMR
75 MHz (CDCl3+TFA)  28.5 (N3-CH3); 28.9 (N1-
CH3); 41.0 (CH2Ph); 107.4 (4a); (124.0, 125.2, 126.4,
127.0 aromatic); 129.2 (C-5); 158.0 (C-7a); 159.2 (C-2);
160.0 (C-4). IR 3220, 3210, 1700 cm−1. MS 285 M+.
CHN analysis (calcd %) C, 58.94; H, 5.26; N, 24.56;
(found %) C, 58.95; H, 5.20; N, 24.55. 3d: mp 262°C.
1H NMR 90 MHz (CDCl3+TFA)  3.00 (s, 3H), 4.25
(s, 2H), 6.70–7.25 (m, 5H). 13C NMR 75 MHz (CDCl3+
TFA)  28.2 (N3-CH3); 41.5 (CH2Ph); 107.4 (4a);
(123.4, 124.2, 125.1, 125.6 aromatic); 130.2 (C-5); 158.8
(C-7a); 159.4 (C-2); 160.2 (C-4). IR 3230, 3220, 3205,
1700 cm−1. MS 271 M+. CHN analyses (calcd %) C,
57.56; H, 4.80; N, 25.83; (found %) C, 57.50; H, 4.85;
N, 25.80.
Although we could not isolate any intermediates from
the reaction mixture a reasonable mechanism for the
formation of the product is outlined in Scheme 2. The
reaction occurs via a nucleophilic attack of the hydra-
zine group onto the carbon atom of the isocyanate to
give compound [I]. The imine [II], which might have
been formed during the reaction suffers another nucle-
ophilic attack by the C-5 atom of the uracil, followed
by elimination of a water molecule to yield the product.
It was interesting to note that the reaction occurred
immediately after the addition of the 6-hydrazino
uracils to the isocyanates and a low yield of the cyclised
product was found (in carefully observed TLC) in the
reaction mixture. The intermediate which could not be
isolated from the reaction mixture due to solubility
problems, cyclised completely on heating in ethanol.
Further study of this effective synthetic method is in
progress. In conclusion, our results demonstrate a very
simple and efficient method for the synthesis of well
functionalised pyrazolo[3,4-d ]pyrimidines of biological
importance in excellent yields. Heteroannulation on the
nucleophilic double bond of uracil, which is an impor-
tant developing field for synthetic manipulation, usually
requires either forcing conditions or relatively long and
complex synthetic pathways. Our results delineated
above have demonstrated that heteroannulation on the
double bond of uracil is possible under simple and
moderate conditions using suitable organic reagents
such as isocyanates.
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